Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 3/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.38 |
| ▸ | NPC1 | O15118 | 2/20 | 0.38 |
| ▸ | RAB9A | P51151 | 2/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | GAA | P10253 | 1/20 | 0.37 |
| ▸ | PRNP | P04156 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.36 |
| ▸ | PPARG | P37231 | 1/20 | 0.36 |
| ▸ | HTT | P42858 | 1/20 | 0.36 |
| ▸ | MAPK10 | P53779 | 1/20 | 0.36 |
| ▸ | NCOA2 | Q15596 | 1/20 | 0.36 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.36 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.36 |
| ▸ | STING1 | Q86WV6 | 2/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13939956 | 0.83 | ALDH1A1 (0.42) | MAPTALDH1A1L3MBTL1KDM4ENPC1 | |
| SCHEMBL3962337 | 0.80 | SERPINE1 (0.46) | MAPTALDH1A1L3MBTL1KDM4ENPC1 | |
| SCHEMBL3962343 | 0.80 | STING1 (0.43) | MAPTALDH1A1L3MBTL1KDM4ENPC1 | |
| SCHEMBL3959212 | 0.79 | TNF (0.44) | MAPTALDH1A1L3MBTL1KDM4ENPC1 | |
| SCHEMBL3967322 | 0.79 | RAB9A (0.38) | MAPTALDH1A1L3MBTL1KDM4ENPC1 | |
| SCHEMBL23787472 | 0.77 | NPC1 (0.60) | MAPTALDH1A1L3MBTL1KDM4ENPC1 | |
| SCHEMBL4071677 | 0.73 | HDAC1 (0.37) | MAPTALDH1A1L3MBTL1KDM4ENPC1 | |
| SCHEMBL21624241 | 0.69 | NPC1 (0.69) | MAPTALDH1A1L3MBTL1KDM4ENPC1 | |
| SCHEMBL31676786 | 0.69 | NPC1 (0.69) | MAPTALDH1A1L3MBTL1KDM4ENPC1 | |
| SCHEMBL30017661 | 0.69 | KDM4E (0.67) | MAPTALDH1A1L3MBTL1KDM4ENPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090023926-A1 | Trityl Derivatives for Enhancing Mass Spectrometry | OXFORD GENE TECHNOLOGY IP LIMITED (GB) | 2009-01-22 | — | — | US | disclosed |
| EP-1802630-A2 | TRITYL DERIVATIVES FOR ENHANCING MASS SPECTROMETRY | OXFORD GENE TECHNOLOGY IP LIMITED (GB) | 2007-07-04 | — | — | EP | disclosed |
| WO-2006032893-A2 | TRITYL DERIVATIVES FOR ENHANCING MASS SPECTROMETRY | OXFORD GENE TECHNOLOGY IP LIMITED (GB) | 2006-03-30 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090023926-A1 | Trityl Derivatives for Enhancing Mass Spectrometry | F3, TBCA, GYPA | MAPT 2875/4885ALDH1A1 1102/4885L3MBTL1 3578/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.